Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: An issue for quality of care

British Journal of Cancer

Volumn 76, Issue 12, 1997, Pages 1640-1645

  Macquart Moulin, G ^a,b   Viens, P ^a,b   Bouscary, M L ^a   Genre, D ^a,b   Resbeut, M ^b   Gravis, G ^b   Camerlo, J ^b   Maraninchi, D ^b,c   Moatti, J P ^a,c  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Breast cancer; Chemotherapy; Physical symptoms; Physician patient communication; Quality of life

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; MITOXANTRONE;

ADJUVANT CHEMOTHERAPY; APPETITE DISORDER; ARTHRALGIA; ARTICLE; BREAST CANCER; CYSTITIS; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FEVER; HAIR LOSS; HEADACHE; HEALTH CARE QUALITY; HOT FLUSH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MOUTH DISEASE; MYALGIA; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RASH; SELF EVALUATION; SIDE EFFECT; STOMACH PAIN; VOMITING;

EID: 0030665682     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.610     Document Type: Article

References (34)

1. Aaronson NK, Ahmedzai S, Bergman B and Cull A (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376
2. Bennett JM, Muss HB, Doroshow JH, Wolff S. Krementz ET, Cartwright K, Dukart G, Reisman A and Schoch I (1988) A randomized multicenter trial comparing Mitoxantrone, Cyclophosphamide, and Fluorouracil in the therapy of metastatic breast carcinoma. J Clin Oncol 6: 1611-1620
3. Blanchard CG, Labreque MS, Ruckdeschel JC, and Blanchard EB (1988) Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med 27: 1139-1145
4. Byrne M (1992) Cancer chemotherapy and quality of life. Cancer trials should include measures of patients' wellbeing. Br Med J 304: 1523-1524
5. Cassileth BR, Zupkis RV, Sutton-Smith K and March V (1980) Information and participation preferences among cancer patients. Ann Intern Med 92: 832-836
6. Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM and Tattersall MHN (1983) On the receiving end - Patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19: 203-208
7. Coates A, Gebski V, Bishop JF, Jeal PN, Woods RL, Snyder R, Tattersall MHN, Byrne M, Harvey V, Gill G, Simpson J, Drummond R, Browne J, Van Cooten R and Forbes JF (1987) Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous strategies. N Engl J Med 317: 1490-1495
8. Cooper S and Georgiou V (1992) The impact of cytotoxic chemotherapy -Perpectives from patients, specialists and nurses. Eur J Cancer 28A: S36-S38
9. Da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, Whelan P, Hetherington J, Fava C, Richards B and Robertson MRG (1996) The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853. Eur J Cancer 32A: 72-77
10. Deber RB (1994) Physicians in health care management: 7. The patient-physician partnership: Changing roles and the desire for information.Can Med Assoc J 151: 171-176
11. Degner LF and Sloan JA (1992) Decision-making during serious illness: what role do patients really want to play ? J Clin Epidemiol 45: 941-952
12. Eddy DM (1990) Anatomy of a decision. J Am Med Assoc 263: 441-443
13. Fallowfield LJ (1992) Behavioural interventions and psychological aspects of care during chemotherapy. Eur J Cancer 28A: S39-S41
14. Fliess JL (1981) Statistical Methods for Rates and Proportions, 2nd edn. pp. 212-236. Wiley: New York
15. Goldberg, RM, Loprinzi CL, O'Fallon JR, Veeder MH, Miser A W, Mailliard JA, Michalak JC, Dose AM, Rowland KM and Burnham NL (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 12: 155-158
16. Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM and Tattersall MHN (1996) On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7: 189-195
17. Knobf MT (1986) Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol 4: 678-684
18. Koller M, Kussman J, Lorenz W, Jenkins M, Voss M, Arens E, Richter E and Rothmund M (1996) Symptom reporting in cancer patients. The role of negative affect and experienced social stigma. Cancer 77: 983-995
19. Landis JR and Koch CG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174
20. Love RR, Leventhal H, Easterling DV and Nerenz DR (1989) Side effects and emotional distress during cancer chemotherapy. Cancer 63: 604-612
21. McIntosh J (1974) Processes of communication, information-seeking and control associated with cancer. Soc Sci Med 8: 167-187
22. Molleman E, Krabbendam PJ, Annyas AA, Schraffordt Koops H, Sleijfer DT and Vermey A (1984) The significance of the doctor-patient relationship in coping with cancer. Soc Sci Med 18: 475-480
23. Morrow GR (1996) The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research. Cancer 53: 2267-2268
24. Nesheim BI, Saetre T (1981) Reduction of menopausal hot flushes by methyldopa: a double blind crossover trial. Eur J Clin Pharmacol 20: 413-416
25. Ong LML, de Haes JCJM, Hoos AM and Lammes FB (1995) Doctor-patient communication: a review of the literature. Soc Sci Med 40: 903-918
26. Payne SA (1992) A study of quality of life in cancer patients receiving palliative chemotherapy. Soc Sci Med 35: 1505-1509
27. Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friandler-Klar H, Coyle N, Smart-Curley T, Kemeny N, Norton N, Hoskins W and Scher H (1994a) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3: 183-189
28. Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Frieandler-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L and Scher H (1994b) The Memorial Symptom Assessment scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30A: 1326-1336
29. Sprangers MAG and Aaronson NK (1992) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol 45: 743-760
30. Steptoe A, Sutcliffe I, Allen B and Coombes C (1991) Satisfaction with communication, medical knowledge, and coping style in patterns with metastatic cancer. Soc Sci Med 32: 627-632
31. Sutherland HJ, Llewellyn-Tomas HA, Lockwood GA, Tritchler DL and Till JE (1989) Cancer patients: their desire for information and participation in treatment decisions. J R Soc Med 82: 260-263
32. Swain SM, Rowland J, Weinfurt K, Berg C, Lippman ME, Walton L, Egan E, King D, Spertus I and Honig SF (1996) Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life. J Clin Oncol 14: 1565-1572
33. Tierney AJ, Leonard RCF, Taylor J, Closs SJ, Chetty U and Rodger A (1991) Side effects expected and experienced by women receiving chemotherapy for breast cancer. Br Med J 302: 272-273
34. Waitzkin H (1984) Doctor-patient communication. Clinical implications of social scientific research. J Am Med Assoc 252: 2441-2446